Follow
Navnita Dutta
Navnita Dutta
Senior Research Technologist, Mayo Clinic
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
A Manna, T Kellett, S Aulakh, LJ Lewis-Tuffin, N Dutta, K Knutson, E Chini, ...
Blood advances 4 (10), 2143-2157, 2020
282020
Trends in early mortality from multiple myeloma: a population-based analysis
V Kumar, M Ailawadhi, N Dutta, M Abdulazeez, CS Aggarwal, G Quintero, ...
Clinical Lymphoma Myeloma and Leukemia 21 (5), e449-e455, 2021
252021
Lisaftoclax (APG-2575) is a novel BCL-2 inhibitor with robust antitumor activity in preclinical models of hematologic malignancy
J Deng, A Paulus, DD Fang, A Manna, G Wang, H Wang, S Zhu, J Chen, ...
Clinical Cancer Research 28 (24), 5455-5468, 2022
142022
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
Cancers 2023 15 (2), 477 https://doi.org/10.3390/cancers15020, 2023
22023
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia
RD Parrondo, N Dutta, BR LaPlant, J Elliott, A Fernandez, A Zimmerman, ...
British Journal of Haematology, 2024
2024
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade
KLK Yan Luo, Barath Shreeder, James W Jenkins, Huashan Shi, Purushottam ...
Journal for Immunotherapy of Cancer 11 (11), doi:10.1136/jitc-2023-007661, 2023
2023
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers
AACK Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D ...
Cancer Medicine https://doi.org/10.1002/cam4.6454, 2023
2023
Analysis of biomarkers in melanoma patients receiving ICI treatments: pre-vs post in responders and progressors
PM Daftarian, N Nadine, O Hushur, R Dronca, N Dutta, KL Knutson
The Journal of Immunology 208 (1_Supplement), 66.14-66.14, 2022
2022
Inhibition of p38 MAPK in dendritic cells enhances their antigen presentation and induces Th17 T cell differentiation
Y Luo, S Barath, DA Bahr, N Dutta, G Raja, MJ Cannon, KL Knutson
Cancer Research 79 (13_Supplement), 1464-1464, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–9